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Background. The prevalence of adolescent pain varies consid-
erably across epidemiological studies, and little information is 
available on pain-related behaviours among adolescents, includ-
ing medicine use. The aims of this study were: [1] to examine the 
prevalence of recurrent pain among 15-year-old adolescents in 
Italy; [2] to investigate the association between recurrent pain 
and medicine use among boys and girls; and [3] to evaluate the 
consistency of these associations across Regions.
Methods. The World Health Organization (WHO) collabo-
rative International Health Behaviour in School-aged Chil-
dren 2013/2014 study collected self-reported data on pain and 
medicine use from 13611 15-year-old adolescents in 21 Italian 
Regions. We used multi-level multivariate logistic regression, 
stratified by gender, to analyse the association between recurrent 
pain and medicine use for headache, stomachache, nervousness 
and difficulties in getting to sleep.
Results. On average, across all Regions, almost 45% of ado-
lescents reported recurrent headache, more than 30% reported 
recurrent backache and approximately 30% reported recurrent 
stomachache. Although the prevalence of both pain and medi-
cine use was much higher among girls, the association between 
pain and medicine use was similarly strong in adolescents of both 
genders. Adolescents with recurrent pain proved more likely to 
use medicines also for non-corresponding pain, nervousness and 
difficulties in getting to sleep. The association between recurrent 
pain and medicine use was consistent across Regions despite large 
inter-regional differences in the prevalence of both phenomena.
Conclusions. Recurrent pain in adolescence is common nation-
wide. Adolescents with recurrent pain are more likely to use 
medicines in general. Recurrent pain and medicine use should be 
addressed by adolescent health policies.
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Introduction
The World Health Organization (WHO) defines adoles-
cence as the age between 10 and 19 years, which con-
stitutes a key period of human growth [1]. Numerous 
studies have shown that about 10-50% of adolescents 
report suffering from recurrent pains. Recurrent pain is 
defined as pain occurring at least once a week within 
the time frame of three or six months. The use of medi-
cines to treat common complaints, such as headache 
and stomachache, is widespread and increasing among 
adolescents [2-6]. Overall, the use of medicines and 
the prevalence of recurrent complaints are much higher 
among girls than boys [7-9]. Studies have demonstrated 
an increasing use of medicines for headache and stom-
achache among girls, and an association between the use 
of medicines and the frequency of the corresponding 
complaints [2, 3]. Adolescents who suffer from recurrent 
pains take medicines more frequently, and it has been 
hypothesized that medicine use during adolescence con-
tinues into adulthood [10]. In general, the use of phar-
maceutical drugs seems to be facilitated by their easy 
accessibility and availability, and by changes in phar-
maceutical regulations and the attitudes of parents, who 
are the primary source of medicines [2, 6, 7]. As adoles-
cents generally have scant knowledge of the use of phar-
maceutical drugs, it seems important, from the public 
health standpoint, to instruct these young people in the 
appropriate use of such medicines and to conduct studies 
in target groups in order to analyse the phenomenon of 
medicine use in greater depth [2, 8, 10]. Although trends 
in the use of medicines have been investigated by several 
in-country studies, the results are difficult to compare 
owing to differences in study populations, data collec-
tion and measurements. The International Health Behav-
iour in School-aged Children (HBSC) study is a single 
tool for the collection of data on medicine use among 
adolescents; as it is based on a unified methodology that 
involves all Italian Regions, it enables direct comparison 
of the data collected.
The aims of the present study were: to determine the 
prevalence of recurrent pains, such as headache, stom-
achache and backache, among 15-year-old adolescents 
in 21 Italian Regions; to evaluate any correlation be-
tween recurrent pains and medicine use among males 
and females; and to assess the possible similarities and 
differences among the Italian Regions considered.
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Materials and methods
Study population
The data utilised were taken from the HBSC Italian 
study, a cross-sectional study promoted by the WHO at 
the international level in order to document health-relat-
ed behaviours among school-age adolescents. Details of 
the method and the investigative tools used to gather the 
data have been reported elsewhere [11-13]. 
Specifically, we used the data from 21 Italian Re-
gions; these were collected from a representative 
sample of adolescents aged 11, 13 and 15 years in 
each Region from 2013 to 2014. In order to obtain 
a random sample of school classes, we implemented 
the strategy of cluster sampling. Data were collected 
by means of an internationally validated question-
naire, which was self-administered (in the presence 
of qualified personnel) in schools, in conformity with 
the national protocol [11]. This questionnaire is sub-
ject to ongoing development and validation by all 
the researchers in the countries participating in the 
international HBSC project. Parental consent to par-
ticipation in the study is mandatory. The study pro-
tocol, which was approved by the Ethics Committee 
of the University of Turin, provided for the use of an 
“opt-out” consent form, meaning that a child would 
be included by default unless his or her parents chose 
to opt out by explicitly refusing consent. All the data 
were collected anonymously, so that the individual 
participants could not be identified. For what con-
cerns the present article, we selected only 15-year-
old adolescents (n = 13611), 6907 girls (50.7%) and 
6704 boys (49.3%), in order to observe the behaviour 
of only those subjects who are more independent in 
their use of medicines (Tab. I). 
Variables
From the HBSC questionnaire, we used the questions 
concerning the following complaints: headache, stom-
achache, difficulties in getting to sleep and nervousness, 
which were measured on a scale ranging from “almost 
every day” to “rarely or never”. Each symptom was di-
chotomized as “recurrent”, if it occurred at least weekly, 
and “not recurrent” otherwise. The percentages of non-
response to the questions were: headache, 0.31%; stom-
achache, backache and nervousness, 0.35%; and diffi-
culty in getting to sleep, 0.38%. 
In addition, the question “Have you taken any medi-
cines or drugs for the following complaints in the last 
month?” was used to assess the recurrence of the use 
of medicines for headache, stomachache, difficulty 
in sleeping and nervousness. The possible response 
options were: no, yes once, and yes more than once. 
In this case, too, the answers were dichotomised into 
yes and no. The percentages of non-response were: 
1.04% to the question regarding medicines for head-
ache; 1.18% for stomachache; 1.13% for nervous-
ness, and 1.16% for sleeping difficulties.
Statistical analysis
The prevalence of the various complaints and of the use 
of medicines among males and females, subdivided by 
Region, was evaluated by means of the chi-square test. 
In all statistical analyses, we applied a significance value 
of 0.05 and 95% confidence intervals. Logistical regres-
sion was used to evaluate the association among the vari-
ous complaints, on considering boys and girls separately. 
The odds ratios (OR) and the confidence intervals were 
then calculated in order to evaluate the association. The 
association between complaints and medicine use was 
evaluated by means of multilevel logistical regression, in 
which the clusters were identified by the Italian Regions. 
Subsequently, we calculated the ORs and the pertinent 
confidence intervals in order to evaluate the association, 
the Median OR (MOR) as a measure of heterogeneity 
in order to assess the random effect of the Regions, and 
the Intra-Class Correlation (ICC), which enabled us 
to assess both the variance within the clusters and the 
variance among the clusters. The ICC thus enables us 
to evaluate the relevance of clustering, i.e. the degree to 
which subjects within the same Region have the same 
outcome [14]. The analyses were carried out by means 
of the R software, version 3.3.3.
Results
Prevalence of recurrent complaints 
On considering all the Italian Regions included in this 
study, a mean of more than 40% of the adolescents sur-
veyed reported suffering from recurrent headache; 27% 
Tab. I. Subdivision of the sample by sex and region.
Italian Regions Boys Girls Total
Abruzzo 262 269 531
Basilicata 209 210 419
Bolzano 170 255 425
Calabria 317 316 633
Campania 313 287 600
Emilia Romagna 340 317 657
Friuli Venezia Giulia 391 354 745
Lazio 241 213 454
Liguria 374 420 794
Lombardia 462 444 906
Marche 319 424 743
Molise 282 277 559
Piemonte 311 306 617
Puglia 285 293 578
Sardinia 204 206 410
Sicilia 299 308 607
Toscana 356 398 754
Trento 299 323 622
Umbria 427 363 790
Val d’Aosta 141 150 291
Veneto 702 774 291
Total 6704 6907 13611
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reported recurrent stomachache, and over 30% recurrent 
backache (Tab. II).
The prevalence of recurrent headache among girls ranged 
from 43.5% in the Autonomous Province of Bolzano to 
67.5% in Campania, while among boys it ranged from 
20% in the Autonomous Province of Bolzano to 36.9% 
in Piedmont, followed by Campania and Val d’Aosta, 
which displayed similar values (36.1%). In general, in 
all of the Regions considered, the prevalence of recur-
rent headache proved to be 1.5-2 times higher in females 
than in males, the difference being statistically signifi-
cant.
The lowest prevalence values were recorded for stom-
achache, especially among males; in this group, the 
lowest value (14.1%) was seen in the Autonomous Prov-
ince of Trento, and the highest (31.2%) in Val d’Aosta. 
Among girls, the highest prevalence of stomachache 
was recorded in Basilicata (43.2%) and the lowest in 
Bolzano (21.9%). The prevalence of stomachache also 
proved to be significantly higher among females than 
among males in practically all the Regions (except in 
Bolzano e Val d’Aosta, in which the difference was not 
significant). 
Different types of recurrent pain were found to co-exist 
in individuals. All recurrent pains, nervousness and dif-
ficulty in getting to sleep were associated (the ORs were 
higher than 1 and statistically significant).
Prevalence of medicine use
The data on the prevalence of medicine use revealed that 
almost half of 15-year-old Italian adolescents use medi-
cines to treat headache, followed by stomachache, the 
use of medicines to treat this complaint being about 1.5 
times more frequent among girls than among boys in all 
the Regions (Tab. III). The use of medicines to allevi-
ate insomnia and nervousness displayed markedly lower 
percentages, and in most of the Regions no significant 
difference emerged between males and females.
With regard to headache, the lowest prevalence of medi-
cine use by boys was recorded in Lazio (26.7%), while 
the highest was seen in Calabria (37.9%). Among girls, 
by contrast, the prevalence proved to be much higher in 
almost all the Regions considered, with the highest per-
centage being recorded in Lombardy (57.6%) and the 
lowest in Marche (44.7%) and Molise (44.8%).
A marked difference was also seen between males and 
females with regard to the use of medicines to treat stom-
achache in most Regions, the greatest difference (almost 
3-fold) being recorded in the Autonomous Province of 
Trento (males 9.6%, females 31.3%). Among males, 
the lowest percentage was seen in Trento (9.6%) and 
the highest in Campania (23.6%); among females, the 
lowest percentage was recorded in Friuli Venezia Giulia 
(28.4%) and the highest in Basilicata (41.6%).
Medicine use among adolescents with 
recurrent complaints
The odds of medicine use for headache and stomach-
ache were substantially higher among adolescents with 
corresponding recurrent pain than among adolescents 
who reported pain less often (Tab. IV). Adolescents with 
recurrent headache or stomachache were more likely to 
use medications for other types of pain, too. 
For both genders, the OR of medicine use for headache 
was 4. Furthermore, those who suffered from recurrent 
headache were twice as likely also to use medicines for 
nervousness and difficulties in getting to sleep. While for 
boys with recurrent stomachache there was four times 
increase in the odds of medicine use for stomachache, 
for girls the OR was 3. Furthermore, among adolescents 
of both genders, those who had stomachache and back-
ache were 1.5 times more likely also to use medicines 
for headache. Regarding the use of medicines for nerv-
ousness and difficulties in getting to sleep, it can be seen 
in Table IV that, among boys, the ORs ranged from 2 to 
2.5 for each complaint and among girls from 1.5 to 2.
Overall, little regional variation was seen in the associa-
tion between medicine use and recurrent pain, as most 
of the calculated MORs were close to 1 and the ICCs 
were close to zero; thus, little of the total variance in the 
use of medicines is due to differences among the Italian 
Regions (Tab. IV).
Discussion
Medicines are commonly used to alleviate such com-
plaints as headache, stomachache, backache, difficulty 
in getting to sleep and nervousness, and their use among 
adolescents is increasing [2-5, 15]. Given that habits 
acquired during adolescence tend to persist into adult-
hood, adolescents constitute a strategic study population 
from the point of view of public health [10, 16]. The 
purpose of the study was threefold. First, we aimed to 
investigate the prevalence of recurrent complaints, such 
as headache, stomachache and backache, among adoles-
cents in 21 Italian Regions in a year time frame (2014). 
Second, we assessed the correlation between recurrent 
complaints and medicine use among males and females. 
Third, we conducted a comparison of data from the Ital-
ian Regions involved in our analysis. The fact that the 
HBSC utilises a common homogeneous method enabled 
us to compare the data gathered in the various Italian 
Regions. The data analysed in our study revealed that the 
prevalence of recurrent complaints among Italian ado-
lescents was high in all the Regions considered, and that, 
in general, such complaints were more common among 
females than among males, as also reported in other stud-
ies [7, 8, 17-19]. The most frequent complaint proved to 
be headache, followed by backache and stomachache. 
Moreover, it emerged that the prevalence of backache 
was higher than that of stomachache, especially among 
males, in the majority of Regions. These data are in line 
with those of other studies, in which backache has been 
observed to be more common than stomachache among 
older adolescents [8]. 
Overall, about half of Italian adolescents make use of 
medicines, particularly in order to alleviate headache, as 
reported in other studies [18, 19], and, in second posi-
tion, stomachache, with medicine use being more fre-
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quent among females than males [3, 6, 7, 9]. These data 
support the conviction that adolescents now have easier 
access to medicines as a result of modifications in phar-
maceutical regulations, more aggressive marketing and 
the changing attitudes of parents, who are the primary 
source of medicines [2, 6, 7]. In addition, the odds of 
medicine use for headache and stomachache were seen 
to be substantially higher among adolescents with corre-
sponding recurrent pain than among those who reported 
less frequent pain in all the regions considered. Interest-
ingly, boys with recurrent stomachache were seen to be 
much more likely to take medicines to treat this com-
plaint than girls; although the medicine taken proved 
to be appropriate to the type of complaint, it should be 
stressed, as already pointed out by the results of national 
and international studies, that adolescent boys should 
not be underestimated as a subgroup at risk of excessive 
medicine use [20, 21]. 
In addition, it emerges from the present study that ad-
olescents suffering from recurrent complaints are also 
more likely to use medicines that are not appropriate to 
the treatment of their specific complaint. This tenden-
cy, which was documented among adolescents of both 
sexes in our study, has been observed in international 
studies, in which adolescents with recurrent complaints 
have been seen to display a greater likelihood of using 
medicines in general and, in particular, medicines that 
are not specific to the treatment of their symptoms [20]. 
Those adolescents who most frequently take medicines 
to alleviate their pain not only report a higher frequency 
of pain, but also a higher frequency of anxiety, depres-
sion and functional disabilities than adolescents who 
make little or no use of medicines [22]. Moreover, the 
tendency to take medicines has been observed more fre-
quently among young people with scant coping resourc-
es and poor self-rated health, and those of lower social 
class [8, 21]. 
A limitation of the present study is its lack of a clinical 
diagnosis of the intensity of each individual complaint 
and the unavailability of data on the social class of the 
respondents’ parents; indeed, previous studies have 
found a correlation between the use of medicines and 
low parental social class, in addition to the conditions 
of having a scant sense of coherence and being a victim 
of bullying [21]. Nevertheless, the subjective perception 
of pain, regardless of its primary cause, is important in 
that it impacts on the adolescent’s general well-being; 
indeed, recurrent pain has a detrimental effect on ado-
lescents’ daily functioning and quality of life [24-27]. 
Overall, the data reported in this study reveal that over 
40% of 15-year-old adolescents in Italy report suffering 
from recurrent headache, followed by stomachache and 
backache. Adolescent girls are more likely to take medi-
cines to treat headache and stomachache, while those 
of both sexes who suffer from recurrent complaints are 
more likely to take medicines that are not intended for 
the treatment of their specific complaint. 
Adolescents’ use of medicines to treat recurrent com-
plaints is a complex phenomenon which needs to be 
properly studied. Indeed, this behaviour may be influ-
enced by many factors, such as the attitudes, social class 
and educational level of parents, which should be taken 
into account. Given that behaviours acquired during ad-
olescence tend to be carried over into adulthood, the re-
current complaints experienced by adolescents may in-
crease the risk of chronic complaints and critical health 
disorders in adulthood [28]. Thus, the use of medicines 
in adolescence is a public health concern and constitutes 
an emerging issue that requires more attention and in-
vestigation on the part of scientific research and greater 
awareness among adults and health professionals.
Tab. IV. Association between propensity to recurrent complaints and medicine use.
Medicines for headache
Medicines for 
stomachache
Medicines for sleeping 
difficulties
Medicines for 
nervousness
Recurrent 
complaint
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Males
Headache
4.14
MOR = 1.03
3.70-4.63
ICC = 0.00003
1.78
MOR = 1.19
1.56-2.04
ICC = 0.01
2.45
MOR = 1.05
1.87-3.21
ICC = 0.001
2.12
MOR = 1.19
1.67-2.70
ICC =0.01
Stomachache
1.80
MOR = 1.06
1.58-2.04
ICC = 0.001
3.85
MOR = 1.19
3.33-4.44
ICC = 0.01
2.67
MOR = 1.09
2.01-3.54
ICC = 0.003
2.52
MOR = 1.16
1.96-3.24
ICC = 0.007
Backache
1.33
MOR = 1.06
1.19-1.50
ICC = 0.001
1.48
MOR = 1.20
1.28-1.70
ICC = 0.01
2.08
MOR = 1.04
1.58-2.74
ICC = 0.0004
1.90
MOR = 1.18
1.49-2.43
ICC = 0.01
Females
Headache
4.38
MOR = 1.14
4.07-4.72
ICC = 0.006
1.55
MOR = 1.03
1.39-1.72
ICC = 0.0004
2.06
MOR = 1.27
1.62-2.61
ICC = 0.02
2.13
MOR = 1
1.73-2.62
ICC = 0
Stomachache
1.67
MOR = 1.12
1.51-1.84
ICC = 0.004
2.89
MOR = 1
2.60-3.21
ICC = 0
2.25
MOR = 1.28
1.81-2.79
ICC = 0.02
1.93
MO = 1
1.61-2.32
ICC = 0
Backache
1.43
MOR = 1.11
1.29-1.58
ICC=0.004
1.42
MOR = 1.05
1.28-1.57
ICC = 0.0008
1.49
MOR = 1.24
1.20-1.85
ICC = 0.02
1.55
MOR = 1
1.29-1.87
ICC = 0
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